These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35962518)

  • 21. Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument.
    Gupta V; Sreenivas V; Mehta M; Khaitan BK; Ramam M
    Br J Dermatol; 2014 Nov; 171(5):1084-90. PubMed ID: 24805089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presentations, Signs of Activity, and Differential Diagnosis of Vitiligo.
    Goh BK; Pandya AG
    Dermatol Clin; 2017 Apr; 35(2):135-144. PubMed ID: 28317523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The possibility of misdiagnosis of generalized vitiligo as pigmentary disease.
    Cho YH; Lee SJ; Lee HJ; Hann SK; Lee MG; Park YK
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1364-6. PubMed ID: 17062080
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of vitiligo severity: patient-reported estimates are not accurate.
    Ukoha UT; Sosa JJ; Hynan LS; Pandya AG
    Br J Dermatol; 2015 Nov; 173(5):1325-6. PubMed ID: 25833124
    [No Abstract]   [Full Text] [Related]  

  • 25. Vitiligo.
    LeWitt TM; Kundu RV
    JAMA Dermatol; 2021 Sep; 157(9):1136. PubMed ID: 34287629
    [No Abstract]   [Full Text] [Related]  

  • 26. Using the blue screen of a smartphone as an alternative to Wood's lamp for examination of vitiligo.
    Agrawal S; Sharma A; Dhurat R; Chahal K
    J Am Acad Dermatol; 2023 Jan; 88(1):e5-e6. PubMed ID: 31015013
    [No Abstract]   [Full Text] [Related]  

  • 27. Refractory vitiligo improving with eculizumab.
    Martinez-Cabriales SA; Bohdanowicz M; Wells R; Shear NH
    Dermatol Ther; 2020 Mar; 33(2):e13233. PubMed ID: 31997487
    [No Abstract]   [Full Text] [Related]  

  • 28. Association of Quality of Life and Location of Lesions in Patients With Vitiligo.
    Florez-Pollack S; Jia G; Zapata L; Rodgers C; Hernandez K; Hynan LS; Pandya AG
    JAMA Dermatol; 2017 Mar; 153(3):341-342. PubMed ID: 28097309
    [No Abstract]   [Full Text] [Related]  

  • 29. Postinflammatory hypopigmentation due to ferrous sulphate.
    Masarà A; Fabbrocini G; Cacciapuoti S; Napolitano M; Patruno C
    G Ital Dermatol Venereol; 2020 Apr; 155(2):243-244. PubMed ID: 29998708
    [No Abstract]   [Full Text] [Related]  

  • 30. Health-related quality of life in paediatric patients with vitiligo: a systematic review and meta-analysis.
    Nathalie J; Chang J; Ezzedine K; Rodrigues M
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e755-e756. PubMed ID: 34013610
    [No Abstract]   [Full Text] [Related]  

  • 31. Vitiligo Iridis in a Patient With a History of Smallpox.
    Mahendradas P; Nahata H; Acharya I
    JAMA Ophthalmol; 2022 Dec; 140(12):e224444. PubMed ID: 36520157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofibromatosis and vitiligo: A simple coincidence or coexistence?
    Ouni NEI; Salah NB; Aounallah A
    Int J Rheum Dis; 2022 Apr; 25(4):506-507. PubMed ID: 35119199
    [No Abstract]   [Full Text] [Related]  

  • 33. Repigmentation of poliosis in a patient with segmental vitiligo.
    Bae JM; Kwon HS; Lee JH; Kim GM
    J Am Acad Dermatol; 2016 Jul; 75(1):e23-4. PubMed ID: 27317537
    [No Abstract]   [Full Text] [Related]  

  • 34. Reliability and validity of the Vitiligo Signs of Activity Score.
    Eleftheriadou V
    Br J Dermatol; 2020 Nov; 183(5):801-802. PubMed ID: 32458411
    [No Abstract]   [Full Text] [Related]  

  • 35. Vitiligo: to biopsy or not to biopsy?
    Mazzei Weiss ME
    Cutis; 2020 Apr; 105(4):189-190. PubMed ID: 32463851
    [No Abstract]   [Full Text] [Related]  

  • 36. Vitiligo effectively treated with electrocautery needling technique.
    Yang L; Wong PM; Yang L; Katayama I; Wu H; Zhang H
    Dermatol Ther; 2020 Nov; 33(6):e14154. PubMed ID: 32767488
    [No Abstract]   [Full Text] [Related]  

  • 37. Association between vitiligo and metabolic syndrome: A systematic review and meta-analysis.
    Chuang KW; Chang HC
    J Dtsch Dermatol Ges; 2022 Feb; 20(2):218-221. PubMed ID: 34990080
    [No Abstract]   [Full Text] [Related]  

  • 38. British Association of Dermatologists guidelines for the management of people with vitiligo 2021.
    Eleftheriadou V; Atkar R; Batchelor J; McDonald B; Novakovic L; Patel JV; Ravenscroft J; Rush E; Shah D; Shah R; Shaw L; Thompson AR; Hashme M; Exton LS; Mohd Mustapa MF; Manounah L;
    Br J Dermatol; 2022 Jan; 186(1):18-29. PubMed ID: 34160061
    [No Abstract]   [Full Text] [Related]  

  • 39. Micropigmentation-A revived therapeutic tool for recalcitrant, difficult-to-treat periungual vitiligo.
    Sharma A; Agrawal S; Dhurat R; Mhatre M; Surve R; Kerure A
    Dermatol Ther; 2020 Jul; 33(4):e13568. PubMed ID: 32401406
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of Cosmetic Camouflage in Adults With Vitiligo.
    Morales-Sánchez MA; Laguna-Meraz JP; Peralta-Pedrero ML; Jurado-Santa Cruz F
    Actas Dermosifiliogr; 2022 Mar; 113(3):316-318. PubMed ID: 35526927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.